Y β SF M β SF
29 1.624 1.45 1000 3.049 2
30 1.776 1.5 1050 2.838 1.905
35 2.446 1.75 1075 2.736 1.86
40 3.049 2 1100 2.635 1.818
45 3.544 2.25 1125 2.536 1.778
1 0 0
28 33 38 43 Beta-Y 990 1010 1030 105
Y (Ksi) SF-Y M
Y β SF M β SF
29 1.624 1.45 1000 3.049 2
30 1.776 1.5 1050 2.838 1.905
35 2.446 1.75 1075 2.736 1.86
40 3.049 2 1100 2.635 1.818
45 3.544 2.25 1125 2.536 1.778
COV-M (%) β SF
5 3.837 2
7.5 3.745 2
10 3.628 2
12.5 3.493 2
15 3.347 2
YZ/M-1
COV-M (%) β SF
5 3.837 2
7.5 3.745 2
10 3.628 2
12.5 3.493 2
15 3.347 2
1.7
990 1010 1030 1050 1070 1090 1110 1130 3.3
2 2.838 2.736 2
2.635 2.536 3.75 2 3.7452 2 2
2.3 1.95
1.905 1.9 3.628
1.4 1.86 1.85
S β
3.6
1.818 F
1.8 3.493
1.778
0.5 1.75 3.45
1.7
-0.4990 1010 1030 1050 1070 1090 1110 11301.65 3.3
4.5 7 9.5 12
M (Kip-in) Beta-
M CoV M (%)
SF-M
F with CoV M (Func1)
2.5
3.745
2 2 2 2 2
3.628
1.5
3.493
S
3.347 1 F
0.5
0
9 11.5 14
Beta-CoV
CoV M (%) M
SF-CoV M
452 2 2 2 2
3.628 1.5
S
1 F
3.493
0.5
3.347
0
452 2 2 2 2
3.628 1.5
S
1 F
3.493
0.5
3.347
0
9.5 12 14.5
Beta-CoV M
CoV M (%) SF with CoV
M
FUNC 1 YZ-M YZ-M
Y β SF M β SF
29 1.371 1.45 1000 2.981 2
30 1.521 1.5 1050 2.832 1.905
35 2.26 1.75 1075 2.758 1.86
40 2.981 2 1100 2.683 1.818
45 3.684 2.25 1125 2.609 1.778
Y β SF M β SF
29 1.155 1.45 1000 2.074 2
30 1.257 1.5 1050 2.036 1.905
35 1.709 1.75 1075 2.014 1.86
40 2.074 2 1100 1.989 1.818
45 2.372 2.25 1125 1.962 1.778
COV-M (%) β SF
5 3.651 2
7.5 3.578 2
10 3.482 2
12.5 3.369 2
15 3.244 2
YZ/M-1
COV-M (%) β SF
5 3.482 2
7.5 3.244 2
10 2.981 2
12.5 2.722 2
15 2.481 2
3.578
2 2 2 2 2
3.482
1.5
3.369 S
1 F
3.244
0.5
0
9 11.5 14
Beta-CoV
CoV M (%) M
SF-CoV M
2 2 2 2 2
44
1.5
2.981 S
1 F
2.722
0.5
2.481
0
2 2 2 2 2
44
1.5
2.981 S
1 F
2.722
0.5
2.481
0
9.5 12 14.5
Beta-CoV M
CoV M (%) SF with CoV
M